Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,140.00
+120.00 (2.99%)
At close: Jul 31, 2026
Market Cap62.81B -26.9%
Revenue (ttm)118.65B +10.9%
Net Income11.15B +101.9%
EPS735.72 +102.4%
Shares Out 15.17M
PE Ratio5.63
Forward PEn/a
Dividend60.00 (1.45%)
Ex-Dividend DateDec 29, 2025
Volume17,572
Open4,050.00
Previous Close4,020.00
Day's Range4,050.00 - 4,200.00
52-Week Range3,900.00 - 6,990.00
Beta0.20
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About Sinsin Pharmaceutical

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 1959
Employees 356
Stock Exchange KOSDAQ
Ticker Symbol 002800
Full Company Profile

Financial Performance

In 2025, Sinsin Pharmaceutical's revenue was 113.78 billion, an increase of 6.95% compared to the previous year's 106.39 billion. Earnings were 9.29 billion, an increase of 90.08%.

Financial Statements